Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 20, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uniqure N.V.
| 6.41K |
$18.88 | -$43,159.68 | +32.77% | 25.99K |
Jun 13 - Jun 16
| |||||||
Uniqure N.V.
| -384.00 |
$20.41 | -$7,837.44 | -1.92% | 19.57K |
Feb 27
| |||||||
Uniqure N.V.
| 9.08K |
—
|
—
| +83.48% | 19.96K |
Jun 15
| |||||||
Uniqure N.V.
| -602.00 |
$16.70 | -$10,053.40 | -5.24% | 10.88K |
Feb 28
| |||||||
Uniqure N.V.
| 1.53K |
—
|
—
| +15.42% | 11.48K |
Feb 24
| |||||||
Uniqure N.V.
| -505.00 |
$37.50 | -$18,937.50 | -4.83% | 9.95K |
Mar 2
| |||||||
Uniqure N.V.
| 2.38K |
—
|
—
| +29.52% | 10.45K |
Feb 25
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 17
| |||||||
Uniqure N.V.
| 2.06K |
—
|
—
| +34.35% | 8.07K |
Feb 27
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Uniqure N.V.
| -807.00 |
$62.19 | -$50,190.36 | -11.85% | 6K |
Jan 28
| |||||||
Syros Pharmaceuticals, Inc.
| 20K |
$4.98 | $99,595.79 | +133.33% | 35K |
Nov 11 - Nov 12
|
Scheduled
| ||||||
Syros Pharmaceuticals, Inc.
| 87K |
—
|
—
| +580.00% | 102K |
Feb 12
| |||||||
Uniqure N.V.
| -1.21K |
$31.32 | -$37,897.20 | -15.08% | 6.81K |
Jan 28
| |||||||
Uniqure N.V.
| 3.23K |
—
|
—
| +67.40% | 8.02K |
Jan 25
| |||||||
Uniqure N.V.
| 4.79K |
—
|
—
|
∞
| 4.79K |
Jan 26
| |||||||
Syros Pharmaceuticals, Inc.
| 15K |
$9.08 | $136,260.00 |
∞
| 15K |
Dec 15
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 13
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Uniqure N.V.
|
0
|
—
|
—
|
—
|
0
|
Sep 20
| |||||||
Uniqure N.V.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.